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Regulatory SNPsa b s t r a c t
Background: Galectin-3 protein, an S-type lectin, is encoded by LGALS3 gene. It consists of carbohydrate
recognition domain (CRD), collagen like tandem repeats of nine amino acids and N-terminal 12-mer pep-
tide. Its serum levels as well as some genetic variants were reported to be involved in various disease con-
ditions like cancer, autoimmune diseases, heart diseases etc. Being viewed as an important molecule in
biological responses and its association with various diseases, the present study was designed. This is
the first in silico analyses of LGALS3.
Aim: To systematically explore the plausible effects of LGALS3 genetic variants on structure and functions
of galectin-3.
Material and methods: Both sequence based and structure based approaches were adopted for analyses of
non-synonymous single nucleotide polymorphisms (nsSNPs). Putative methylation and other post trans-
lational modifications were also analyzed using different tools. Muster and Swiss-PDB Viewer were used
for modeling of predicted functional variants.
Results: Out of 1130 SNPs reported in dbSNP, only validated SNPs were chosen for analyses. A total of
nine nsSNPs which included, 3 of N-terminal region and 6 of CRD encoding region, were found to have
deleterious effect as predicted by various softwares. Analyses of regulatory SNPs predicted five functional
SNPs in 30UTR having putative miRNA binding sites and 3 intronic SNPs in potential transcription factor
binding sites.
Conclusion: Based on these analyses, the present study suggested that the reported functional SNPs may
act as potential targets in genetic association studies.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Galectin-3, a chimera type member of galectin family, is also
being known as a potent immuno-regulator. It is encoded by a sin-
gle gene LGALS3 located on chromosome 14q22.3. LGALS3 gene
consists of 6 exons and 5 introns spanning a total of approximately
17 kb of total genome. Exon I and part of exon II encodes un-
translated region of the gene, while translation initiation site is
located on other part of exon II [1]. Galectin-3 molecule consists
of carbohydrate recognition domain (CRD) and N-terminal region
including collagen like tandem repeats of nine amino acids Tyro-
Pro-Gly-(Pro/Gln)-(Ala/Thr)-(Pro/Ala)-Pro-Gly and 12-mer peptide
sequence [2–3]. N-terminal region is encoded by exon III, whileCRD is encoded by exon IV, V and VI (Fig. 1). N-terminal region con-
sists of 100–150 amino acids and it directs the secretion of
galectin-3 molecule by non-classical pathway. On the other hand,
CRD consists of about 135 amino acids and exhibits carbohydrate
recognition activity. The biological role of galectin-3 protein is
defined by its varied cellular localization. It may be found intra-
cellularly in nucleus or in cytoplasm and extra-cellularly on cell
surface or in extracellular space [4–5]. It was reported to be
involved in various biological processes such as cellular homeosta-
sis, cell adhesion, angiogenesis, cell signaling, cellular growth, dif-
ferentiation, cell cycle and apoptosis [6]. Consequently, it was
viewed as an important molecule in aberrant immune responses
and in tumorigenesis [7–9]. Several single nucleotide gene poly-
morphisms (SNPs) have been identified in LGALS3, harboring intro-
nic, exonic and untranslated regions (UTRs).
SNPs are the simplest form of variations and source of 90% of
variations reported in human population [10]. These can be of
many types including synonymous SNPs, non-synonymous SNPs
Fig. 1. Gene and protein structure of galectin-3 (adopted from Kadrofske et al., 1998).
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that nsSNPs play a major role in the functional diversity of encoded
proteins and have been linked with many disease conditions [11–
12]. These SNPs may affect the protein function by reducing pro-
tein solubility or by destabilizing protein structure [13]. The other
variants in promoter or intronic regions may affect gene regulation
by altering transcription and subsequently translation through
altered transcription factor binding sites or splicing sites [14].
Variations in LGALS3 gene were also found to be associated with
various pathological conditions including cancers and autoimmune
diseases [15–17]. Genetic analysis of all the SNPs of a particular
gene for susceptibility towards any disease is not of much
relevance. Moreover, it becomes even more challenging to study
all the genetic determinants on large sized population based
studies. So, it becomes mandatory to prioritize the functional SNPs,
from the plethora of SNPs, to target in genetic and functional
studies.
Taking into account all these considerations, the present study
was undertaken to explore the possible effects of various LGALS3
variants on the structure and function of galectin-3 using different
computational tools. To the best of our knowledge, this is the first
comprehensive and systematic in silico analyses of LGALS3 gene.
2. Material and methods
2.1. Data mining
The data on human LGALS3 gene was retrieved from Entrez
Gene from National Center for Biological Information (NCBI) data-
base. The SNP information (reference sequence ID) and protein
sequence (accession number) of the LGALS3 gene were retrieved
from NCBI dbSNP (http://www.ncbi.nlm.nih.gov/snp/) and Swis-
sProt (http://expasy.org/) databases respectively.
2.2. Identification of deleterious nsSNPs
To determine the functional impact (deleterious, damaging or
neutral), coding nsSNPs were analyzed using five different tools.
This ensured the stringency and accuracy of results at the time of
screening and only to be likely deleterious variations were further
subjected for other analyses like effect on 3D structure, surface
accessibility and energy changes using different tools.
SIFT (Sorting intolerant from tolerant) server was used to iden-
tify the tolerated and deleterious SNPs. The effect of amino acid
substitution (AAS) on protein structure was assessed on the basis
of degree of conservation of amino acids using sequence homology
(http://siftdna.org/www/SIFT_dbSNP.html). Substitution of anamino acid at each position with probability < 0.05 is predicted
to be deleterious and intolerant, while probability  0.05 is consid-
ered as tolerant [18]. Out of various reported nsSNPs, a total of 36
nsSNPs were filtered out on the basis of their validation, which
were further used as input for SIFT. The input query was submitted
in the form of SNP rs IDs.
Polyphen (polymorphism and phenotype) server was used to
predict the functional impact of amino acid substitution on protein
structure and function based on sequence based characterization
(http://genetics.bwh.harvard.edu/pph2/). Prediction outcome was
obtained in the form of probability score which classifies the vari-
ations as ‘probably damaging’, ‘possibly damaging’ and ‘benign’
[19]. UniProt KB protein accession ID P17931 along with position
and name of wild type and variant amino acids of screened nsSNPs
were submitted as query.
nsSNP Analyzer, a web based server, was used to predict the
disease associated variations based on integrated information on
multiple sequence alignment and 3D structure analysis of protein
(http://snpanalyzer.utmem.edu/). Additionally, it also provides
the structural environment of SNP including solvent polarity, sec-
ondary structure and solvent accessibility [20]. Protein sequence
along with the list of nsSNPs defining wild type and mutant amino
acid residues were submitted as input for analysis.
SNPs & GO web server was used to predict the human disease
related mutations (http://snps.biofold.org/snps-and-go). This ser-
ver was mainly based on support vector machines which can cor-
roborates all the information regarding variations from the existing
databases. It annotates variations as deleterious based on informa-
tion derived from Gene Ontology (GO) Predictor with overall accu-
racy of 82% [21]. UniProt accession ID of LGALS3 (P17931) along
with name and position of wild type and mutant amino acid was
submitted as input for this server.
PANTHER (Protein Analysis Through Evolutionary Relationship)
was used to classify the proteins on the basis of their evolutionary
relationship, molecular functions and interaction with other pro-
teins (http://www.pantherdb.org/tools.). Analysis was based on
substitution position specific evolutionary conservation score, cal-
culated from alignment of different evolutionarily related proteins
[22]. Query was submitted as Protein FASTA sequence along with
AAS.
Mutpred was used to predict structural and functional changes
as a consequence of AAS (http://mutpred.mutdb.org/). These
changes were expressed as probabilities of gain or loss of structure
and function. It also provided the information regarding specific
molecular mechanism responsible for the disease [23]. The input
was provided in form of protein FASTA sequence along with amino
acid substitution.
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accessibility and secondary structure
I-Mutant2.0 is a tool used for prediction of changes in protein
stability due to single site mutations under different conditions
(http://gpcr.biocomp.unibo.it/cgi/predictors/I-Mutant2.0/I-Mutan-
t2.0.cgi). It is a web server based on support vector machine which
worked on dataset derived from Protherm, a database of experi-
mental records on protein mutations. It can predict the stability
changes in protein with 80% accuracy based on its structure and
with 77% of accuracy based on its sequence [24]. The input can
be submitted as either in the form of protein sequence or on a
structure basis. For the present study, input was submitted in the
form of protein FASTA sequence.
NetSurfP server predicts the surface accessibility and secondary
structure of amino acids on the basis of their sequence (http://
www.cbs.dtu.dk/services/NetSurfP/). The reliability of this predic-
tion method is in the form of Z-score. The Z-score highlights the
surface prediction reliability, but not associated with secondary
structure [25].
PSIPRED is a secondary structure prediction method based on
neural networks (http://globin.bio.warwick.ac.uk/psipred/). Analy-
sis performed by PSIPRED achieved an average Q score of 80% [26].
Protein FASTA sequence was submitted as input query for this tool.2.4. Prediction of various post translational modifications
Post translational modifications affect a variety of important
biological processes including cell signaling, metabolic pathways
etc. Putative phosphorylation sites were predicted using NetPhos
2.0 (http://www.cbs.dtu.dk/services/NetPhos) and GPS 2.1
(http://gps.biocuckoo.org/) [27–28]. Putative ubiquitylation sites
were predicted using the UbPred (www.ubpred.org) and BDM-
PUB (bdmpub.biocuckoo.org) programs [29]. Putative sumoylation
sites and palmitoylation sites were predicted using respective
SUMOsp 2.0 (http://sumosp.biocuckoo.org/) and CSS-Palm soft-







Fig. 2. Pie diagram depicting count of validated SNPs analyzed for computational
analysis.2.5. Modeling the phenotypic effects of nsSNPs on protein structure
MUSTER (v1.0), a valuable threading tool, was used for protein
structure prediction (http://zhanglab.ccmb.med.umich.edu/MUS-
TER/). It provided the Z-score and complete full length models by
using MODELLER v8.2. Sequence-derived profiles, secondary struc-
tures, structured-derived profiles, solvent accessibility, backbone
torsion angles and hydrophobic scoring matrix are the six different
sources used by MUSTER [30].
I-TASSER creates the full length protein models by excising con-
tinuous fragments from threading alignments and further recon-
structs them using replica exchanged Monte Carlo simulations
(http://zhanglab.ccmb.med.umich.edu/I-TASSER/). The quality of
predicted structure is estimated by I-TASSER in the form of confi-
dence score. These are used to predict the quality of the modeling
prediction by calculating the distance between two predicted mod-
els [31].
Swiss-PDB Viewer (v4.04) was used to generate the mutated
models of each of the selected PDB entries for the corresponding
amino acid substitutions. Swiss-PDB Viewer allows browsing
through a rotamer library to change amino acids. A ‘‘mutation tool’’
was used to replace the native amino acid with a new one. The
mutation tool facilitates the replacement of the native amino acid
by the ‘‘best’’ rotamer of the new amino acid. The energy mini-
mization for 3D structures was performed by the NOMAD-Ref ser-
ver. This server uses Gromacs as the default force field for energy
minimization based on the methods of steepest descent, conjugategradient, and L-BFGS [32]. The galectin-3 PDB file named 1KJR was
used as input for generating mutated models.
2.6. Predicting molecular effects of regulatory SNPs
PolymiRTS (Polymorphism in miRNA target site) is a web based
server used for analyzing the functional impact of genetic poly-
morphisms in microRNA (miRNA) seed regions and miRNA target
sites (http://compbio.uthsc.edu/miRSNP). This program also pro-
vided the information regarding miRNA-mRNA binding sites and
small INDEL variations in miRNA seed regions and miRNA target
sites [33]. The reference sequence ID NM_0023006 for LGALS3
was submitted as input for this server.
SNPinfo server is a set of web based various selection tools
including Gene pipe, Genome pipe, Linkage pipe, Taq SNP, Func
Pred, SNPseq, which were used to select functional SNP for genetic
association studies (http://snpinfo.niehs.nih.gov/). This algorithm
predicts functional impact of both coding and non-coding SNPs
based on GWAS and candidate gene information [34]. LGALS3, the
name of gene was submitted as a query for this program.
RegulomeDBwas used to identify putative regulatory potential
functional variants (F:/in%20silico/regulome%20db/rs1009977.ht
ml). It used high-throughput experimental data sets from ENCODE
and other sources, as well as computational predictions and man-
ual annotations to identify functional determinants. These data
sources are combined into a powerful tool that scores variants to
help to separate functional variants from a large pool and provides
a small set of putative sites with testable hypotheses as to their
function [35]. The reference sequence IDs of all non-coding SNPs
were submitted as query input.
3. Results
As per dbSNP database, a total of 1130 validated and non-
validated SNPs were reported for LGALS3 gene. Out of these, only
610 validated SNPs were investigated further for computational
analyses. These included 54 coding SNPs, 2 SNPs harboring 50UTR,
51 of 50 near genes, 3 of 30UTR SNPs, 16 of 30near genes and 484
were intronic SNPs (Fig. 2). Out of 54 coding SNPs, 16 were found
to be synonymous SNPs and 38 were nsSNPs. Among nsSNPs, one
was non-sense variant, one frameshift variant and rest others were
mis-sense variants.
3.1. Deleterious or disease associated variations and their effects on
protein structure, stability and solvent accessibility
Out of 36 mis-sense nsSNPs analyzed by SIFT, 10 variations (5 of
N-terminal region and 5 of CRD) were found to be deleterious with
Table 2





rs568100150 L11I Decrease 0.59
rs199980622 G38R Increase 0.46
rs200440596 P46R Decrease 0.66
rs201423229 G47R Decrease 0.14
rs4644 P64H Decrease 0.53
rs372168966 P67L Decrease 0.83
rs370418608 I132V Decrease 0.02
rs376506811 R162C Decrease 0.85
rs201865041 R162H Decrease 2.07
rs542583325 E185G Decrease 1.37
rs373019488 P191L Increase 1.33
rs564378578 R224Q Decrease 0.74
rs540554467 L234R Decrease 1.74
rs1042869 S237F Decrease 1.53
rs150161752 I240T Decrease 2.49
rs138668217 Y247H Decrease 0.10
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erated with tolerance index  0.05 (Table 1). The basic amino acids
arginine (R), histidine (H) and lysine (K) were the most likely sub-
stituted amino acids as deleterious impact of SNPs. Analysis by
Polyphen predicted the probably damaging effect of 13 SNPs. Fur-
thermore, only one substitution L11I was found to have possibly
damaging effect. Rest all variations showed benign effect on pro-
tein. A total of 13 variations were found to be disease associated
as predicted by nsSNPAnalyzer. In consonance with Polyphen and
SIFT results, seven variations were found to have disease associ-
ated effects. However, in contrast to Polyphen and SIFT, neutral
effects of G47R and P64H were predicted by nsSNP analyzer. Pre-
diction of functional nsSNPs was also confirmed using SNPs & GO
and PANTHER. The variations R162C, R162H, E185G, P191L and
R224Q were found to have disease associating effects by both of
these tools (Table 1). Possible molecular mechanism by which a
deleterious variation associated with disease state was further pre-
dicted by Mutpred. Majority of predicted effects included alter-
ation in methylation status and glycosylation, change in solvent
accessibility and altered disorderness in secondary structure of
protein. Deleterious and disease associated variations along with
their predicted effect is given in Table 1. Decrease stability of pro-
tein with respective energy changes was observed for all deleteri-
ous mutations except G38R and P191L (Table 2). NetSurfP server
was used for prediction of surface accessibility and secondary
structure of amino acids. Class assignments of ‘buried’ and ‘ex-
posed’ were given to amino acids as per their location in protein
structure. Out of various nsSNPs submitted, class assignment had
been changed for only three mutations including A97P (exposed
to buried), L114V (buried to exposed) and E185G (buried to
exposed). The other SNPs did not show any alteration in their
respective class assignment (Suppl Table 1).3.2. Prediction of putative methylation, phosphorylation, sumolyation
and ubiquitination sites
Besides Mutpred, various other tools were used to identify dele-
terious variations having putative phosphorylation, ubiquitination
etc. sites. The four putative phosphorylation sites harboring delete-
rious variations were predicted by GPS 2.1. These included serine/Table 1
Deleterious and disease associated variations predicted by various softwares.
SNP ID Amino acid
change
SIFT Polyphen nsSNP anal
rs568100150* L11I – Possibly damaging Disease
rs199980622* G38R Deleterious Probably damaging Disease
rs200440596* P46R Deleterious Probably damaging Disease
rs201423229* G47R Deleterious Probably damaging Neutral
rs4644* P64H Deleterious Probably damaging Neutral
rs372168966* P67L Deleterious Probably damaging Disease
rs370418608 I132V Deleterious Benign Neutral
rs376506811 R162C Deleterious Probably damaging Disease
rs201865041 R162H Deleterious Probably damaging Disease
rs542583325 E185G – Probably damaging Disease
rs373019488 P191L Deleterious Probably damaging Disease
rs564378578 R224Q – Probably damaging Disease
rs540554467 L234R – Probably damaging Disease
rs1042869 S237F Tolerated Probably damaging Disease
rs150161752 I240T Deleterious Probably damaging Disease
rs138668217 Y247H Tolerated Benign Disease
* Variations lie in N-terminal domain, other variations lie CRD region; – not determinthreonine phosphorylation at 98, 188 and 237 positions. The muta-
tions at these sites resulted in loss of respective phosphorylation.
In contrast to this, only one phosphorylation site at position 188,
was predicted by Netphos. Amino acid substitution at positions
153 and 183 resulted in significant gain of ubiquitination,
while no ubiquitination sites were observed with respective wild
type amino acids at these positions as predicted by Ubpred. No
sumolyation and palmitoylation sites were observed at wild type
amino acids as well as their substituted counterparts in galectin-
3 molecule. Different variations harboring deleterious effects as
predicted by above said tools as well as by Mutpred are depicted
in Fig. 3.
3.3. Modeling of amino acid substitution effects due to nsSNPs on
protein structure, energy minimization
The available structure of LGALS3 was retrieved from RCSB-
Protein data bank with ID 1KJR. The structure accounted only of
CRD harboring 113–250 amino acid residues with this ID. The
structure of N-terminal region has not been reported in PDB data-
base till date. Only those mutations which were found to haveyzer SNP &GO PANTHER Predicted Effect By Mutpred
Neutral – No significant effect
Neutral – Gain of methylation, loss of relative
solvent accessibility
Neutral – Gain of methylation, loss of glycosylation
Neutral – Gain of methylation, loss of relative
solvent accessibility
Neutral – Loss of relative solvent accessibility,
loss of glycosylation
Neutral – Loss of relative solvent accessibility,
loss of glycosylation
Neutral Neutral No significant effect
Disease Deleterious Loss of disorder
Disease Deleterious No significant effect
Disease Deleterious Loss of MoRF binding
Disease Deleterious Loss of disorder, loss of methylation
Disease Deleterious No significant effect
Neutral Neutral Gain of disorder, Gain of methylation,
Gain of MoRF binding, loss of stability
Neutral Neutral Loss of disorder, loss of glycosylation
Neutral Neutral Gain of disorder, loss of stability
Neutral Neutral Gain of disorder
ed by software.
Table 3
List of SNPs spanning miRNA target sites and seeds.
dbSNP ID Type of
variant
Allele miR ID Function
class*
Variants in miRNA target sites

















rs182580267(T/C) SNP C hsa-miR-6757-5p C




Variants in miRNA seeds
rs148982635(G/A) SNP G/A hsa-miR-4749-3p D
rs200056596(C/T) SNP C/T hsa-miR-4749-3p D
Fig. 3. Variations harboring putative methylation, glycosylation, phosphorylation and ubiquitination sites (drawn by IBS software).
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the effect of substitution on structure of protein. On this basis, a
total of 9 variations were predicted to be deleterious, which
involved 3 of N-terminal region and 6 harbored in CRD. An effort
was made to predict the complete secondary structure of
galectin-3 protein (including N-terminal region and CRD) so as to
model the substitution effect for both N-terminal and CRD varia-
tions through homology modeling. MUSTER provided the complete
full length models along with coverage, sequence identity and Z-
score using MODELLER v8.2. All the templates provided by MUS-
TER had coverage of approximately 0.5 with alignment of only
CRD sequence (PDB ID- 1KJR) (Suppl Table 2). However, no tem-
plate was found for N-terminal sequence. So modeling of amino-
acid substitutions was performed only for CRD variations.
Six functional mutations of CRD including rs376506811
(R162C), rs2018650419 (R162H), rs542583325 (E185G),
rs373019488 (P191L), rs564378578 (R224Q) and rs150161752
(I240T) were subjected to Swiss-PDB Viewer mutation tool. Signif-
icant structural changes were observed in mutated models of
R162C and R162H in comparison to their native structure. The vari-
ant R162C possessed a significant substitution from a large basic
amino acid to small polar amino acid. Molecular simulations anal-
ysis revealed that R162C (9.275 kcal/mol) and R162H
(9.270 kcal/mol) showed accountable difference in their total
energy after energy minimization as compared to native structure
(9.564 kcal/mol).* C – site created, D – site disrupted.3.4. Prediction of putative miRNA target sites
30UTR serve as putative target sites for miRNA, an important
regulator of gene expression. Single nucleotide change in these
regions may either disrupt or create new target sites for miRNA.
The SNPs rs61975414, rs1042906, rs1825065 and rs1042918 were
predicted to affect the miRNA target sites. Besides this,
rs149894805, an INDEL variant was also found to alter the miRNA
site. The detailed impact of these SNPs on various miRNAs was
listed in Table 3. Two variations rs148982635 and rs200056596
were also found to exist in miRNA seeds which resulted in disrup-
tion of their putative target sites.3.5. SNPs affecting transcription factor binding site
The non-coding regions including intronic and UTR of LGALS3
serve as putative binding sites for transcription factors as well as
splicing. A single nucleotide change at these positions may alter
the binding and subsequently affect transcription or splicing mech-
anisms. Out of plethora of SNPs tested, 43 SNPs having minor allele
frequency  1% were predicted to affect transcription binding as
indicated by their respective RegulomeDB score. Only those SNPs
which were having scores  4 are listed in Table 4. RegulomeDB
Table 4
Functional impact of non-coding variations.
SNP /INDEL SNPs harboring TFBS*
Regulomedb SNPinfo











rs3832943 3a Less likely to affect binding TF binding+any motif+DNase peak
rs369628908
rs2075598 2b Likely to affect binding TF binding+any motif+DNasefootprint+DNase peak
* TFBS – Transcription factor binding site, TF – Transcription factor.
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effect on transcription factor binding. Two SNPs rs3832943 and
rs369628908 were found to have 3b score conferring less likely
effect on binding. The other 10 SNPs listed in Table 4 were recorded
to have score of 4 with minimal binding evidence. The same attri-
bute of SNPs to affect transcription factor binding site (TFBS) was
also predicted by SNPinfo. The results indicated that out of 13 func-
tional SNPs predicted by RegulomeDB, only three SNPs i.e.
rs12161901, rs8012397 and rs 61975412 were observed to affect
TFBS in SNPinfo (Table 4).4. Discussion
A plethora of SNPs has been distributed in human genome. Due
to their association with different diseases, these variations can
preferentially act as genetic markers [36]. Studying such a large
number of SNPs in case-control association studies offers a great
challenge for scientists. Computational analyses provide a major
insight to predict those SNPs which can potentially affect the struc-
ture and function of the encoded protein in any way. Galectin-3 is
an important molecule with well implicated role in various
pathologies including cancer and inflammatory diseases [8–9,17].
So, in the present study an effort was made to identify functionally
important non-synonymous and regulatory SNPs in human LGALS3
gene.
A systematic approach including both sequence based and
structure based study was undertaken for computational analyses
of nsSNPs. Sequence based approach offered an advantage that it is
suitable for proteins having closely related members. Based on this
approach, both N-terminal and CRD harbored variations of LGALS3
were investigated. Out of 36 nsSNPs, a total of nine variations were
found to be deleterious by at least three tools. Decrease in protein
stability due to these variations further potentiates their functional
impact. Analysis of these variations by Ensembl indicated that all
these variations were found to be expressed in conserved regions.
It has been evidenced that conserved regions are biologically very
important, so variations in these regions may lead to potential
functional changes. The adverse effects of these variations were
also observed on protein stability. A couple of variations were also
observed to alter methylation, glycosylation and other post trans-
lational modifications. Significant gain or loss of methylation had
been observed in G38R, P46R, P47R, P191L and L234R variations.
DNA methylation is a key regulator in transcription and altered
effect of methylation behavior has been implicated in many dis-
eases like cancer, atherosclerosis, aging etc. [37–38]. The evidencesof hyper-methylation in galectin-3 gene also come from the vari-
ous studies in cancer [39–41]. Another SNP rs4644 (P64H) was also
identified as deleterious by SIFT and Polyphen tools. It is a con-
served variation harbored in N-terminal region which involves
substitution of C with A, replacing proline with histidine in
galectin-3 protein. His64 renders galectin-3 molecule susceptible
towards cleavage by matrix metallo-proteinases (MMPs) resulting
in loss of self association property and alterations in glycan binding
properties [42]. This variation was also indicated to result in loss of
glycosylation and relative solvent accessibility. Thus, it was pre-
dicted to severely affect the biological functions leading to various
anomalies. This finding of present study was strongly evidenced
from experimental data conducted in our lab as well from perusal
of literature indicating genetic association of P64H with rheuma-
toid arthritis and breast cancer [15,43–44]. As far, no such experi-
mental data has been available in literature for other variations
predicted to be deleterious by the present study. So, the results
of present study may provide a guidelines for prioritizing the SNPs
for further genetic association studies.
Further, sequence based approach was unable to explain the
underlying mechanism to study genotype-phenotype relation-
ships. So, another approach based on structure was undertaken
to predict the effect of variations on secondary structure, surface
accessibility and binding properties of protein. As far, 3-D structure
of galectin-3 protein is available only for CRD, not for N-terminal
region. So, the structure based predictions were implemented only
for variations harboring CRD. b-pleated sheets along with random
coils attributed towards secondary structure of galectin-3 protein
as predicted by PSIPRED. No change in 20 structures has been
observed for R162C, R162H and P191L variations. Furthermore,
NetSurfP tool revealed that surface accessibility of these SNPs in
secondary structure remains unaffected due to amino acid substi-
tutions. The putative ligand binding site in galectin-3 protein har-
bored Arg 162 and polymorphism at this position, either R162C or
R162H, may affect its binding properties. Taken this in considera-
tion, R162C and R162H were proposed as potential candidate tar-
gets for various genetic association studies.
The present study predicted five SNPs in miRNA target site and
two SNPs in miRNA seed region. These SNPs may alter miRNA
binding site and hence affect subtle gene regulation and it may
ultimately lead towards disease susceptibility. The evidence comes
from recent experimental studies indicating SNPs in miRNA target
sites of BRCA1, TGF-b genes subsequently contributing towards
likelihood of cancer [45–46]. As far, no such experimental data
has been reported for LGALS3 gene. Thus, non-coding SNPs also
emerged as important target for genome wide disease association
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gene regulation. SNPs in regulatory binding sites may affect the
expression of gene and altered expression may lead to pathological
conditions. Three SNPs were found to affect TFBS predicted by two
different tools independently. The regulatory SNPs of AKT3, ATF3,
VEGFA etc. were found to play an important role in susceptibility
towards cancer [14]. The literature till date documented no such
experimental study for regulatory SNPs of galectin-3. Thus, the
use of in silico SNP prioritization strategies provides an excellent
framework for the identification of functional SNPs. As these com-
putational tools are machine based algorithms, so, further valida-
tion with experimental investigations and clinical evidences are
warranted to complement the findings of the present study.
5. Conclusion
In silico analyses estimated the probability with which coding as
well as non-coding variations are likely to have potential impact
either on protein structure, function or its regulation. These func-
tional genetic determinants can also act as potential diagnostic
and therapeutic targets for different diseases. Some findings of
the present study have already been experimentally validated by
our lab as well as other research groups. Follow up studies to elu-
cidate the role of other functional SNPs of LGALS3 gene in the eti-
ology of complex diseases are underway in our lab.
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